Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 142 No. 3334 (2012)

Cancer, a disease of aging (part 2) – risk factors for older adult cancer mortality in Switzerland 1991–2008

  • Kurt Schmidlin
  • Adrian Spoerri
  • Matthias Egger
  • Marcel Zwahlen
  • Andreas Stuck
  • Kerri M. Clough-Gorr
Cite this as:
Swiss Med Wkly. 2012;142:w13607


PRINCIPLES: Cancer is disease of aging that disproportionately affects older adults and often results in considerable public health consequences. This study evaluated gender-age-specific cancer mortality risk factors in older adults in Switzerland with attention to the most common types of cancer.

METHODS: The population included all individuals ≥65 years old based on 1990/2000 censuses linked to mortality records through end of 2008. Cancer mortality relative risk was assessed by gender-age-specific all-cancer and cancer-specific mortality hazard ratios (HR) with 95% confidence intervals (CI) from adjusted Cox proportional hazards regression models.

RESULTS: The risk profile of dying from cancer was similar in older men and women across most socio-demographic characteristics: higher cancer mortality risk with lower educational attainment (all-cancer men HR = 0.84 [95%CI 0.82, 0.85] tertiary, HR = 1.09 [95%CI 1.07, 1.10] compulsory, women all-cancer HR = 0.95 [95%CI 0.92, 0.98] tertiary, HR = 1.03 [95%CI 1.02, 1.05] compulsory) and unmarried marital status. Cancer mortality risk factors varied less than hypothesised across older age-groups. However, for outcomes and characteristics with age-specific variation the oldest (≥85 years) generally showed the lower cancer mortality relative risk (except for non-Swiss lung cancer risk).

CONCLUSION: These comprehensive epidemiological results indicate that in Switzerland (like other developed countries) age alone is not the only important cancer risk factor and risk is not necessarily the same across older age-groups; providing additional needed information about the aging-cancer nexus. However, additional studies especially with consideration of stage of disease, treatments received and comorbidity are needed.


  1. World Health Organization (WHO) Cancer Mortality Database. In Edition World Health Organization 2011.
  2. Chiolero A, Gervasoni JP, Rwebogora A, Mkamba M, Waeber B, Paccaud F, et al. Discordant prevalence of hypertension using two different automated blood pressure measurement devices: a population-based study in Dar es Salaam (Tanzania). Blood Press Monit. 2004;9:59–64.
  3. Switzerland Statistics of Cancer Incidence 1984–2008. In Edition Zurich, Switzerland: National Institute for Cancer Epidemiology and Registration 2010.
  4. Switzerland Statistics of Cancer Mortality 1984–2008. In: Edition Zurich & Neuchâtel, Switzerland: National Institute for Cancer Epidemiology and Registration & Swiss Federal Statistics Office 2010.
  5. The population of Switzerland 2009. In: Edition Neuchâtel, Switzerland: Federal Department of Home Affairs, Swiss Federal Statistical Office 2010.
  6. Robine JM, Paccaud F. Nonagenarians and centenarians in Switzerland, 1860–2001: a demographic analysis. J Epidemiol Community Health. 2005;59:31–7.
  7. UNDATA. In: Edition United Nations Statistics Division 2011.
  8. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569.
  9. Pallis AG, Fortpied C, Wedding U, Van Nes MC, Penninckx B, Ring A, et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer. 46:1502–13.
  10. Ershler WB. Cancer: a disease of the elderly. J Support Oncol. 2003;1:5–10.
  11. Levi F, La Vecchia C, Randimbison L. Cancer mortality in Switzerland, 1990–1994. Soz Praventivmed. 1997;42:37–54.
  12. Levi F, Lucchini F, La Vecchia C. Trends in cancer mortality in Switzerland, 1980–2001. Eur J Cancer Prev. 2006;15:1–9.
  13. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer. 2004;101:2843–50.
  14. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44:1345–89.
  15. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002;38:99–166.
  16. Bopp M, Spoerri A, Zwahlen M, Gutzwiller F, Paccaud F, Braun-Fahrländer C, et al. Cohort Profile: the Swiss National Cohort – a longitudinal study of 6.8 million people. Int J Epidemiol. 2009;38:379–84.
  17. Spoerri A, Zwahlen M, Egger M, Bopp M. The Swiss National Cohort: a unique database for national and international researchers. Int J Public Health. 2010;55:239–42.
  18. Fair M. Generalized record linkage system – Statistics Canada’s record linkage software. Austrian J Stat. 2004;33:37–53.
  19. Fellegi IP, Sunter AB. A theory of record linkage. J Am Stat Assoc. 1969;64:1183–210.
  20. Proceedings of the 4th Stromboli Conference on Aging and Cancer, June 6–11, 2005, Sicily, Italy. Ann N Y Acad Sci. 2005;1057:1–571.
  21. Renaud A. Methodology Report – Coverage Estimation for the Swiss Population Census 2000. In Edition Neuchâtel, Switzerland: Swiss Federal Statistical Office 2004.
  22. Doria-Rose VP, Marcus PM. Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project. Lung Cancer. 2009;63:295–300.
  23. Doria-Rose VP, Marcus PM, Miller AB, Bergstralh EJ, Mandel JS, Tockman MS, Prorok PC. Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials. Clin Trials. 2010;7:69–77.
  24. Schmidlin K, Clough-Gorr KM, Spoerri A, Egger M, Zwahlen M. Impact of unlimited deaths and coding changes on mortaliry estimates in the Swiss national Cohort. BMC Public Med Inform Decis. Submitted.
  25. Data Analysis and Statistcial Software (STATA). In: Edition 11.1. College Station, TX: StataCorp LP 2009.
  26. ArcGIS. In Edition 10. Redlands, CA: ESRI 2010.
  27. Lawson AB, Browne WJ, Vidal Rodeiro CL. Disease Mapping with WinBUGS and MLwiN. Chichester, UK: John Wiley & Sons Ltd 2003.
  28. WinBugs. In: Edition 1.4. Cambridge, UK: 2003.
  29. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ. 1999;319:508–12.
  30. Fast Stats: An interactive tool for access to SEER cancer statistics. In Edition Bathesda, MD: National Cancer Institute.
  31. Vercelli M, Capocaccia R, Quaglia A, Casella C, Puppo A, Coebergh JW. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol. 2000;35:161–79.
  32. Balducci L, Beghe C. Cancer and age in the USA. Crit Rev Oncol Hematol. 2001;37:137–45.
  33. Yang L, Fujimoto J, Qiu D, Sakamoto N. Trends in cancer mortality in the elderly in Japan, 1970–2007. Ann Oncol 2009.
  34. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Changed trends of cancer mortality in the elderly. Ann Oncol. 2001;12:1467–77.
  35. Franceschi S, La Vecchia C. Cancer epidemiology in the elderly. Crit Rev Oncol Hematol. 2001;39:219–26.
  36. Braaten T, Weiderpass E, Kumle M, Lund E. Explaining the socioeconomic variation in cancer risk in the Norwegian Women and Cancer Study. Cancer Epidemiol Biomarkers Prev. 2005;14:2591–7.
  37. Mouw T, Koster A, Wright ME, et al. Education and risk of cancer in a large cohort of men and women in the United States. PLoS One 2008;3:e3639.
  38. Albano JD, Ward E, Jemal A, Anderson R, Cokkinides VE, Murray T, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;99:1384–94.
  39. Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R; EUROCARE Working Group. Comparative cancer survival information in Europe. Eur J Cancer. 2009;45:901–8.
  40. Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer. 2009;45:1006–16.
  41. Extermann M. Interaction between comorbidity and cancer. Cancer Control. 2007;14:13–22.
  42. Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582–7.
  43. Biganzoli L, Goldhirsch A, Straehle C, Castiglione-Gertsch M, Therasse P, Aapro M, et al. Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG). Ann Oncol. 2004;15:207–10.
  44. Chouliara Z, Kearney N, Stott D, Molassiotis A, Miller M. Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature. Ann Oncol. 2004;15:1596–602.
  45. Gagliese L. Aging and the management of cancer pain. Ann Oncol. 2009;20:1752.
  46. Giacalone A, Blandino M, Spazzapan S, Tirelli U. Cancer and aging: are there any differences in the information needs of elderly and younger patients? Results from an Italian observational study. Ann Oncol. 2005;16:1982–3.
  47. Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol. 2007;25:1858–69.
  48. Herzog TN, Scheuren FJ, Winkler WE. Data quality and record linkage techniques. NewYork, New York: Springer 2007.

Most read articles by the same author(s)

1 2 > >>